Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis
NCT06330077
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Remitting Relapsing Multiple Sclerosis
Interventions
DRUG:
Ifenprodil
DRUG:
Placebo
Sponsor
Assistance Publique - Hôpitaux de Paris